Stereotactic radiosurgical capsulotomy may eventually help treat people with treatment-resistant major depressive disorder.

Sustained tobacco abstinence rates among medically underserved adults referred for lung cancer screening are higher with financial incentives.

The FDA has cleared Motivista, the first prescription digital therapeutic indicated to treat negative symptoms of schizophrenia as an adjunct to antipsychotic therapy.

Most youths with opioid use disorder do not receive medications for OUD or engage in care, leading to a higher rate of overdose deaths.

Higher levels of exhaled carbon monoxide are linked to a decreased risk for Parkinson disease in adults without a history of smoking.

Dexmedetomidine administration is rising in opioid use disorder-related hospitalizations due to medetomidine appearing in illicit fentanyl.

A brief psychosocial intervention for older adults initiating antidepressants improves illness perceptions compared with standard care.

Laxative misuse and dietary restriction in bulimia nervosa are associated with specific structural brain changes including lower hippocampal volume.

Topline phase 3 ARISE trial results show oral solengepras 150mg significantly reduces OFF time and improves motor/non-motor function in Parkinson disease.

A novel machine learning model accurately screened for psychologic distress in patients with chronic rhinosinusitis using routine clinical variables.

Around 1 in 9 older adults in the US have used cannabis in the past 12 months meet the criteria for cannabis use disorder.

Worse parent-reported asthma control among children with asthma is associated with household e-cigarette and household tobacco use.